Public Health News and Research

RSS

Newly developed fusion protein could improve COVID-19 research

Researchers at the Paul Scherrer Institute in Switzerland have developed a high-quality recombinant virus protein that could be applied in the development of vaccines against the 2019 novel coronavirus (2019-nCoV) and in the detection of novel viruses or antibodies.

30 Sep 2020

What we know about the airborne spread of the coronavirus

The federal government did a quick pivot on the threat of the coronavirus spreading through the air, changing a key piece of guidance over the weekend.

30 Sep 2020

Persistent-poverty counties face high risk of cancer mortality

Residents of counties that experience persistent poverty face a disproportionately high risk of cancer mortality, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

30 Sep 2020

Danish vs. Swedish data shows social interaction major risk factor for SARS-CoV-2 infection

A new study published on the preprint server medRxiv* in September 2020 compares the prevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Danish and Swedish healthcare workers, to conclude that “social interaction is one of the biggest risk factors for getting infected with SARS-CoV-2.”

30 Sep 2020

New research supports evidence of airborne transmission of COVID-19 in enclosed spaces

New research from the University of Georgia supports growing evidence for airborne transmission of COVID-19 in enclosed spaces.

30 Sep 2020

Political leaders and media should acknowledge uncertainties in epidemiological models, shows study

Scientists, policymakers and the media should acknowledge inherent uncertainties in epidemiological models projecting the spread of COVID-19 and avoid "catastrophizing" worst-case scenarios, according to new research from Cornell University.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

Novel nasal treatment could protect people from COVID-19

A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.

30 Sep 2020

Mobile health applications can address patients' long-term rehabilitative needs

Serious traumatic injuries are a health event that can begin a trajectory toward chronic health and social challenges.

30 Sep 2020

College football crowds could impact COVID-19 spread

The observed increase in COVID-19 cases coinciding with the reopening of college campuses all over the US has drawn intense scientific attention. A recent paper, by Washington State University researchers, published on the preprint server medRxiv* in September 2020 reports that this threat is directly linked to the holding of in-person sporting events on these campuses.

29 Sep 2020

Australian scientists develop a nasal spray that could stop SARS-CoV-2 infection

The novel product, called INNA-051, is being developed by Ena Respiratory, and laboratory experiments have shown that it reduced viral replication by as much as 96 percent in the animal study. Spearheaded by Public Health England’s (PHE) Deputy Director, Professor Miles Carroll, the new study described the potential treatment and has been published in the open-source preprint server bioRxiv*.

29 Sep 2020

Discovery of specific kinase as a novel drug target against SARS-CoV-2 and other coronaviruses

By using a modern genome-wide knockout approach to single out coronavirus host factors in human cells, researchers from Rega Institute in Belgium discovered a potential new target that might be exploited for developing drugs against the ongoing coronavirus disease (COVID-19) pandemic, but also future outbreaks of highly pathogenic coronaviruses

29 Sep 2020

Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial

Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine.

29 Sep 2020

UC researchers find potential treatment that could be applied to COVID-19

By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.

29 Sep 2020

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.

29 Sep 2020

Corralling the facts on herd immunity

For a term that's at least 100 years old, "herd immunity" has gained new life in 2020.

29 Sep 2020

Normal conversations can spread exhaled particles inside buildings

With implications for the transmission of diseases like COVID-19, researchers have found that ordinary conversation creates a conical 'jet-like' airflow that quickly carries a spray of tiny droplets from a speaker's mouth across meters of interior space.

29 Sep 2020

Girls participating in sports show improved behavior, attentiveness in early adolescence

Girls - but not boys - who participate actively in school sports activities in middle childhood show improved behavior and attentiveness in early adolescence, suggests a new Canadian study published in Preventative Medicine.

29 Sep 2020

WHO offers guideline on managing pharmaceutical prices

Unaffordable prices can be one of the biggest barriers to access to pharmaceutical products. A new WHO guideline for countries on managing pharmaceutical prices aims to help governments overcome this barrier and better address national public health needs.

29 Sep 2020

Public Health News and Research

Newly developed fusion protein could improve COVID-19 research

What we know about the airborne spread of the coronavirus

Persistent-poverty counties face high risk of cancer mortality

Danish vs. Swedish data shows social interaction major risk factor for SARS-CoV-2 infection

New research supports evidence of airborne transmission of COVID-19 in enclosed spaces

Political leaders and media should acknowledge uncertainties in epidemiological models, shows study

COVID-19 has created a perfect storm for people with heart disease

COVID-19 has created a perfect storm for people with heart disease

Novel nasal treatment could protect people from COVID-19

Mobile health applications can address patients' long-term rehabilitative needs

College football crowds could impact COVID-19 spread

Australian scientists develop a nasal spray that could stop SARS-CoV-2 infection

Discovery of specific kinase as a novel drug target against SARS-CoV-2 and other coronaviruses

Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial

UC researchers find potential treatment that could be applied to COVID-19

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

Corralling the facts on herd immunity

Normal conversations can spread exhaled particles inside buildings

Girls participating in sports show improved behavior, attentiveness in early adolescence

WHO offers guideline on managing pharmaceutical prices

News Medical 2025: Healthcare Shifts That Mattered Most eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News